C Altaner

Summary

Affiliation: Slovak Academy of Sciences
Country: Slovakia

Publications

  1. pmc Characterization of mesenchymal stem cells of "no-options" patients with critical limb ischemia treated by autologous bone marrow mononuclear cells
    Cestmir Altaner
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia St Elisabeth Cancer Institute, Bratislava, Slovakia
    PLoS ONE 8:e73722. 2013
  2. doi request reprint Stem cell based glioblastoma gene therapy
    C Altaner
    Cancer Research Institute SAS, Bratislava, Slovakia
    Neoplasma 59:756-60. 2012
  3. pmc Tumor cell behaviour modulation by mesenchymal stromal cells
    Lucia Kucerova
    Laboratory of Molecular Oncology, Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia
    Mol Cancer 9:129. 2010
  4. ncbi request reprint Genotoxic damage of human adipose-tissue derived mesenchymal stem cells triggers their terminal differentiation
    V Altanerova
    Laboratory of Molecular Oncology, Cancer Research Institute, Bratislava, Slovakia
    Neoplasma 56:542-7. 2009
  5. ncbi request reprint Glioblastoma and stem cells
    C Altaner
    Cancer Research Institute SAS Bratislava, Slovakia
    Neoplasma 55:369-74. 2008
  6. ncbi request reprint Human glioma cells expressing herpes simplex virus thymidine kinase gene treated with acyclovir, ganciclovir and bromovinyldeoxyuridine. Evaluation of their activity in vitro and in nude mice
    K Hlubinova
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 48:398-406. 2001
  7. ncbi request reprint Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene
    A Pastorakova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 53:478-84. 2006
  8. ncbi request reprint Combine cancer gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and Herpes simplex thymidine kinase suicide gene
    A Pastorakova
    Cancer Research Institute, Slovak Academy of Sciences, 83391 Bratislava, Slovak Republic
    Neoplasma 53:353-62. 2006
  9. ncbi request reprint Tumor targeted gene therapy with plasmid expressing human tumor necrosis factor alpha in vitro and in vivo
    A Pastorakova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 52:344-51. 2005
  10. ncbi request reprint Influence of diet containing lyophilized Enterococcus faecium M-74 with organic selenium on tumor incidence in Apc1638N mice
    K Hlubinova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 51:341-4. 2004

Collaborators

  • J Ban
  • L Kucerova
  • J Bodo
  • K Hlubinova
  • A Pastorakova
  • V Altanerova
  • M Babincov
  • A Soltysova
  • V Altanerov
  • B Rychly
  • P Babinec
  • M Poturnajova
  • M Babincova
  • M Matuskova
  • E Horvathova
  • C Bergemann
  • J Jakubikova
  • J Libby
  • G Margison
  • L Ebringer
  • J Knotek
  • M Podobov
  • J Matoska
  • J Hlavaty
  • J Breza
  • R Kettmann
  • I Balazovjech
  • S Feikova
  • G Fodo
  • M Sramka
  • M Lampert
  • E Machová

Detail Information

Publications16

  1. pmc Characterization of mesenchymal stem cells of "no-options" patients with critical limb ischemia treated by autologous bone marrow mononuclear cells
    Cestmir Altaner
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia St Elisabeth Cancer Institute, Bratislava, Slovakia
    PLoS ONE 8:e73722. 2013
    ..We examined which properties of bone marrow stromal cells also known as bone-marrow derived mesenchymal stem cells of responding and non-responding patients are important for amputation-free survival...
  2. doi request reprint Stem cell based glioblastoma gene therapy
    C Altaner
    Cancer Research Institute SAS, Bratislava, Slovakia
    Neoplasma 59:756-60. 2012
    ..Encouraging results of preclinical studies of stem cell based gene therapy for glioblastoma support the argument to begin clinical studies...
  3. pmc Tumor cell behaviour modulation by mesenchymal stromal cells
    Lucia Kucerova
    Laboratory of Molecular Oncology, Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia
    Mol Cancer 9:129. 2010
    ..We aimed to show whether multipotent MSC derived from human adipose tissue (AT-MSC) could create tumor cell-protective milieu and affect tumor cell behaviour in vitro and in vivo...
  4. ncbi request reprint Genotoxic damage of human adipose-tissue derived mesenchymal stem cells triggers their terminal differentiation
    V Altanerova
    Laboratory of Molecular Oncology, Cancer Research Institute, Bratislava, Slovakia
    Neoplasma 56:542-7. 2009
    ..Surviving cells after genotoxic stress were not transformed but underwent replicative senescence. Irreparable DNA damage caused triggered adipogenic terminal differentiation, rather than apoptosis induction in all kinds of cells tested...
  5. ncbi request reprint Glioblastoma and stem cells
    C Altaner
    Cancer Research Institute SAS Bratislava, Slovakia
    Neoplasma 55:369-74. 2008
    ..BMP4 may act as a key inhibitory regulator of cancer initiation and therefore may be used in combined stem cell-based therapy as a non-cytotoxic therapeutic agent...
  6. ncbi request reprint Human glioma cells expressing herpes simplex virus thymidine kinase gene treated with acyclovir, ganciclovir and bromovinyldeoxyuridine. Evaluation of their activity in vitro and in nude mice
    K Hlubinova
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 48:398-406. 2001
    ..Therefore the effect of GCV treatment on 8-MG-BA xenografts inoculated with PA-317JH5cl13 virus producer cells was further studied on nude mice...
  7. ncbi request reprint Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene
    A Pastorakova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 53:478-84. 2006
    ..Whether the bicistronic vector containing both therapeutic genes improve the therapy need to be assessed in the future...
  8. ncbi request reprint Combine cancer gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and Herpes simplex thymidine kinase suicide gene
    A Pastorakova
    Cancer Research Institute, Slovak Academy of Sciences, 83391 Bratislava, Slovak Republic
    Neoplasma 53:353-62. 2006
    ..Whether the bicistronic plasmid containing both genes would improve the therapeutic effect need to be assessed in the future...
  9. ncbi request reprint Tumor targeted gene therapy with plasmid expressing human tumor necrosis factor alpha in vitro and in vivo
    A Pastorakova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 52:344-51. 2005
    ..This strategy may be a simple and promising gene therapy approach to the treatment of some human tumors...
  10. ncbi request reprint Influence of diet containing lyophilized Enterococcus faecium M-74 with organic selenium on tumor incidence in Apc1638N mice
    K Hlubinova
    Cancer Research Institute, Slovak Academy of Sciences, 833 91 Bratislava, Slovak Republic
    Neoplasma 51:341-4. 2004
    ..Feeding of Apc1638N transgenic mice with enriched diet with probiotic components during 8 months have shown a minor therapeutic effect on the clinical manifestations in small intestine in comparison with control group...
  11. ncbi request reprint The human homologue of the bovine leukemia virus receptor BLVRcp1 is the delta-subunit of adaptor-related AP-3 protein that does not bind the BVLgp51
    J Ban
    Cancer Research Institute of the Slovak Academy of Sciences, Bratislava, Slovakia
    Arch Virol 144:2013-22. 1999
    ..This finding implies that this BLVgp51 binding site is present only on the bovine BLVRcp and therefore its human homologue cannot be recognized by BLVgp51. This might also explain the resistance of human cells to BLV infection...
  12. ncbi request reprint Site-specific in vivo targeting of magnetoliposomes using externally applied magnetic field
    M Babincova
    Department of Biophysics, Comenius University, Bratislava, Slovakia
    Z Naturforsch C 55:278-81. 2000
    ..Difference between the relative radioactivity in the magnetically targeted right kidney (25.92+/-5.84%) and non-targeted left kidney (0.93+/-0.05%) is sufficiently high for relevant clinical applications...
  13. ncbi request reprint Cancer stem cells
    A Soltysova
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic
    Neoplasma 52:435-40. 2005
    ..Further characterization of cancer stem cells is needed in order to find ways to destroy them, which might contribute significantly to the therapeutic management of malignant tumors...
  14. doi request reprint In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia
    M Babincov
    Department of Nuclear Physics and Biophysics, Comenius University, Bratislava, Slovakia
    IEEE Trans Nanobioscience 7:15-9. 2008
    ....
  15. ncbi request reprint Suppression of tumorigenicity in clones of hamster cells transformed with avian sarcoma virus
    V Altanerova
    Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Czechoslovakia
    Neoplasma 35:207-13. 1988
    ..The isolated nontumorigenic cells represent cell mutants in which the viral src gene is controlled by a suppressor gene. The cells might be useful for further characterization of a putative antioncogene...
  16. ncbi request reprint Germline mutation of the RET proto-oncogene in members of Slovak families with multiple endocrine neoplasia 2
    M Poturnajova
    Cancer Research Institute, Slovak Academy of Sciences Bratislava
    Neoplasma 48:445-50. 2001
    ..The data indicate that the mechanism of MEN2 syndrome is not only due to the RET gene mutation, and strongly support the conclusion that additional genetic events are involved in the disease formation...